Cargando…
Mesoporous Silica-Based Nanoparticles as Non-Viral Gene Delivery Platform for Treating Retinitis Pigmentosa
Background: Gene therapy is a therapeutic possibility for retinitis pigmentosa (RP), in which therapeutic transgenes are currently delivered to the retina by adeno-associated viral vectors (AAVs). Although their safety and efficacy have been demonstrated in both clinical and preclinical settings, AA...
Autores principales: | Valdés-Sánchez, Lourdes, Borrego-González, Sara, Montero-Sánchez, Adoración, Massalini, Simone, de la Cerda, Berta, Díaz-Cuenca, Aránzazu, Díaz-Corrales, Francisco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026300/ https://www.ncbi.nlm.nih.gov/pubmed/35456263 http://dx.doi.org/10.3390/jcm11082170 |
Ejemplares similares
-
Retinal pigment epithelium degeneration caused by aggregation of PRPF31 and the role of HSP70 family of proteins
por: Valdés-Sánchez, Lourdes, et al.
Publicado: (2019) -
Dissecting the role of EYS in retinal degeneration: clinical and molecular aspects and its implications for future therapy
por: Garcia-Delgado, Ana B., et al.
Publicado: (2021) -
Retinal Vascular Degeneration in the Transgenic P23H Rat Model of Retinitis Pigmentosa
por: Fernández-Sánchez, Laura, et al.
Publicado: (2018) -
Unravelling the genetic basis of simplex Retinitis Pigmentosa cases
por: Bravo-Gil, Nereida, et al.
Publicado: (2017) -
Astrocytes and Müller Cell Alterations During Retinal Degeneration in a Transgenic Rat Model of Retinitis Pigmentosa
por: Fernández-Sánchez, Laura, et al.
Publicado: (2015)